Mumbai, June 25, 2025 — In a landmark moment, Influx Healthtech Ltd, a leading CDMO (Contract Development and Manufacturing Organization), was officially listed on the NSE Emerge platform, listing at ₹132.50 per share — a strong 38% premium over its issue price of ₹96. This marks a historic day in the company’s journey, signaling growing investor confidence in India's fast-evolving health and wellness sector.
 

Influx Healthtech operates across a diverse portfolio, including Nutraceuticals, Cosmeceuticals, Ayurvedic products, Veterinary feed supplements, and Home care solutions. With manufacturing facilities based in Palghar, Maharashtra, the company has rapidly expanded its operations by leveraging innovation, strict quality standards, and strategic contract manufacturing partnerships.
 

The funds raised will be used to scale up production capacity, acquire key equipment, and support working capital needs. This listing is not just a financial milestone — it represents a strategic leap for Influx Healthtech, reinforcing its mission to be a trusted manufacturing partner in India’s wellness and life sciences space. The strong listing premium also reflects investor belief in the company’s growth trajectory and sectoral strength.

June 25, 2025, will be remembered as a historic day for Influx Healthtech Ltd., as it transitioned into a publicly listed enterprise on NSE Emerge, the SME platform of NSE, setting the stage for its next phase of growth and industry leadership.